Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.


OBJECTIVE Takayasu arteritis (TAK) is a large-vessel vasculitis that induces damage to the aorta and its branches. Glucocorticoids remain the gold standard of therapy for TAK. The nature of the T cells driving vascular inflammation and the effects of glucocorticoids on the systemic components of TAK are not understood. The aim of this study was to analyze T… (More)
DOI: 10.1002/art.39037


  • Presentations referencing similar topics